Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment
暂无分享,去创建一个
M. Choti | J. Cameron | T. Pawlik | N. Ahuja | R. Hruban | B. Edil | elliot k fishman | G. Poultsides | R. Schulick | R. Tuli | Lyen C. Huang | J. Herman | Leslie Lan
[1] 유희철. 간담췌 종양에 대한 American Joint Committee on Cancer (AJCC) 종양 병기 7판 소개 , 2010 .
[2] M. Sim,et al. Small Bowel Adenocarcinoma: Understaged and Undertreated? , 2010, Annals of Surgical Oncology.
[3] M. Choti,et al. Clinicopathologic Analysis of Ampullary Neoplasms in 450 Patients: Implications for Surgical Strategy and Long-Term Prognosis , 2010, Journal of Gastrointestinal Surgery.
[4] H. Cárdenes,et al. Non‐ampullary duodenal adenocarcinoma: Factors important for relapse and survival , 2009, Journal of surgical oncology.
[5] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[6] Jeffrey S. Morris,et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] C. Ko,et al. Small Bowel Cancer in the United States: Changes in Epidemiology, Treatment, and Survival Over the Last 20 Years , 2009, Annals of surgery.
[8] Jeffrey S. Morris,et al. Chemotherapy with 5‐fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma , 2008, Cancer.
[9] S. Choi,et al. Prognostic Factors for Primary Duodenal Adenocarcinoma , 2008, World Journal of Surgery.
[10] C. Willett,et al. Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. , 2007, International journal of radiation oncology, biology, physics.
[11] H. Nava,et al. Surgical Management and Outcome in Primary Adenocarcinoma of the Small Bowel , 2007, Annals of Surgical Oncology.
[12] K. Lillemoe,et al. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. , 2007, Archives of surgery.
[13] J. Pickleman,et al. Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection? , 2007, American journal of surgery.
[14] R. Kozol,et al. Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry. , 2007, Archives of surgery.
[15] H. Friess,et al. Randomized clinical trial of pylorus‐preserving duodenopancreatectomy versus classical Whipple resection—long term results , 2005, The British journal of surgery.
[16] L. Kvols,et al. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. , 2005, The oncologist.
[17] W. Hop,et al. Pylorus Preserving Pancreaticoduodenectomy Versus Standard Whipple Procedure: A Prospective, Randomized, Multicenter Analysis of 170 Patients With Pancreatic and Periampullary Tumors , 2004, Annals of surgery.
[18] J. Gibbs. Duodenal Adenocarcinoma: Is Total Lymph Node Sampling Predictive of Outcome , 2004, Annals of Surgical Oncology.
[19] D. Klimstra,et al. Adenocarcinoma of the Duodenum: Importance of Accurate Lymph Node Staging and Similarity in Outcome to Gastric Cancer , 2004, Annals of Surgical Oncology.
[20] K. Campbell,et al. Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2: Randomized Controlled Trial Evaluating Survival, Morbidity, and Mortality , 2002, Annals of surgery.
[21] C. Ko,et al. Primary duodenal adenocarcinoma: a 40-year experience. , 2000, Archives of surgery.
[22] J. Donohue,et al. What prognostic factors are important in duodenal adenocarcinoma? , 2000, Archives of surgery.
[23] K. Lillemoe,et al. Periampullary adenocarcinoma: analysis of 5-year survivors. , 1998, Annals of surgery.
[24] Katherine S. Virgo,et al. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population , 1996, Cancer.
[25] D. Pezet,et al. Adenocarcinoma of the duodenum: Factors influencing survival , 1994, The British journal of surgery.
[26] J. Forster,et al. Improving resectability and survival in patients with primary duodenal carcinoma. , 1993, American journal of surgery.
[27] R. Rossi,et al. Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection. , 1992, Archives of surgery.
[28] F. FernándezdelaGandara,et al. Primary carcinoma of the duodenum , 1977 .
[29] Jun Cheng,et al. The Surgical Treatment and Outcome for Primary Duodenal Adenocarcinoma , 2010, Journal of gastrointestinal cancer.
[30] K. Lillemoe,et al. Adenocarcinoma of the duodenum: factors influencing long-term survival , 2007, Journal of Gastrointestinal Surgery.
[31] K. Hess,et al. Primary adenocarcinoma of the duodenum: Management and survival in 67 patients , 2006, Annals of Surgical Oncology.
[32] A. Livingstone,et al. Extent of resection in the management of duodenal adenocarcinoma. , 2000, American journal of surgery.
[33] K. Ouriel,et al. Adenocarcinoma of the small intestine. , 1984, American journal of surgery.
[34] A. Andersson,et al. Primary carcinoma of the duodenum. , 1980, Annals of surgery.